Stephens Consulting, LLC Kymera Therapeutics, Inc. Transaction History
Stephens Consulting, LLC
- $399 Billion
- Q1 2025
A detailed history of Stephens Consulting, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Stephens Consulting, LLC holds 15 shares of KYMR stock, worth $714. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15Holding current value
$714% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KYMR
# of Institutions
181Shares Held
67.4MCall Options Held
223KPut Options Held
241K-
Price T Rowe Associates Inc Baltimore, MD6.7MShares$319 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.46MShares$308 Million2.86% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$286 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$286 Million1.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.23MShares$249 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.61B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...